# History and Physical

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Benny Leonard (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-BX008-SYN-TD
- Date: 1946-05-12
- Fictional facility: St. Posthumous Health Center
- Fictional author: Miriam Okafor-Rosenthal, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

## Reason for visit

Establishing primary care at 50 after a referee's license examination found high blood pressure: exertional breathlessness and chest tightness while refereeing, an ECG showing left ventricular hypertrophy, cardiovascular risk, money worries and mood, and a cardiology consultation. **S**

## Historical basis

- Benjamin Leiner was born on April 7, 1896, in New York City, to Gershon Leiner, a tailor, and Minnie Leiner, Orthodox Jewish immigrants from Russia, and grew up on the Lower East Side of Manhattan. **D**
- He began fighting professionally at about fifteen and took the name Benny Leonard to keep his boxing secret from his parents, because boxing was not thought a respectable living in their community. **D**
- He won the world lightweight championship from Freddie Welsh on May 28, 1917, and held it until he retired as undefeated champion in January 1925, at his mother's wish. **D**
- The son of Orthodox Jews, he never fought on a Jewish holiday and became a symbol of the acceptance of Jews in American life at a time of open antisemitism; the newspaper editor Arthur Brisbane wrote that he had done more to conquer anti-Semitism than a thousand textbooks. He later supported the Maccabiah Games. **D**
- Retired, he had become wealthy; in his own words he was practically a millionaire, without a scratch. **D**
- He lost most of his savings in the 1929 stock market crash and in October 1931, at 35, came back as a welterweight; he won about nineteen fights in a row before Jimmy McLarnin knocked him out in the sixth round in October 1932, and he retired for good. **D**
- During the Second World War he served in the U.S. Maritime Service of the Merchant Marine, rising to lieutenant commander. **D**
- He returned to boxing as a referee of professional bouts in New York and also taught boxing at City College of New York. **D**

2 later historical claims are omitted because they describe events after the index age. See the teaching note.

These claims are historical evidence, not findings from a real modern examination.

## History of present illness

This fictional modern episode addresses the presenting concerns below. **S**

- Breathless and tight in the chest late in long nights in the ring, and told his blood pressure is high. **S**
- He needs his refereeing work and is afraid of losing his license. **S**
- Worry about money since losing his savings years ago, and about the cost of medicines. **S**

## Strengths and supports

- Engagement in care and meaningful activity **S**

## Medications and allergies

- Losartan 50 mg with hydrochlorothiazide 12.5 mg, one tablet each morning **S**
- No known allergy **S**

## Past medical history

True biography with historical dates; these events are not part of the synthetic care timeline.

- No historical medical events recorded.

## Procedures and immunizations

- 1946-05-12 to 1946-05-12: Resting 12-lead ECG: sinus rhythm at 78 per minute; left ventricular hypertrophy by voltage (Sokolow-Lyon 38 mm, Cornell 24 mm) with mild lateral T-wave flattening; PR 160 ms; QRS 96 ms; QTc 418 ms; no Q waves, pre-excitation, conduction block or Brugada pattern **S**


## Family history

- No family medical history is documented in the logged sources. Family history of real relatives is never synthesized.

## Measurements

Sodium: 140 mmol/L; Potassium: 4.1 mmol/L; Urea nitrogen: 15 mg/dL; Creatinine: 0.98 mg/dL; eGFR: 93 mL/min/1.73 m²; Glucose: 96 mg/dL; Hemoglobin: 14.6 g/dL; ALT: 24 U/L; HbA1c: 5.5%; TSH: 1.9 mIU/L; Urine albumin-to-creatinine ratio: 22 mg/g{creat}; Total cholesterol: 234 mg/dL (high); HDL cholesterol: 44 mg/dL; LDL cholesterol (calculated): 160 mg/dL (high); Triglycerides: 150 mg/dL (high); Lipoprotein(a): 42 nmol/L; PHQ-9: 5; GAD-7: 6; AUDIT-C: 2. All results are synthetic.

BP 164/100 mmHg; pulse 78 bpm; respirations 16/min; temperature 36.7 °C; oxygen saturation 97% on room air; weight 74.6 kg; BMI 27.4 kg/m². All vital signs are synthetic.

## Examination

Mental status: Alert, articulate and good-humored, with quick wit; worried about money and his license; PHQ-9 5 with item 9 scored 0; GAD-7 6. Functional status: Independent and working; climbs three flights of stairs without stopping; breathless and tight in the chest only late in long cards in hot arenas. Physical examination is intentionally limited. **S**

## Assessment

1. Breathlessness and tightness across the chest on exertion for about two months, late in long nights of refereeing in hot arenas, easing within a few minutes of rest; never at rest; no fainting, palpitations, orthopnea or ankle swelling; cause under evaluation with a cardiology consultation; status draft. **S**
2. Stage 2 hypertension found at a yearly fitness examination for his referee's license (164/100 and 160/98 mmHg), with left ventricular hypertrophy by voltage on the ECG; untreated; home readings to follow; status draft. **S**
3. Hypercholesterolemia: LDL 160 mg/dL, HDL 44 mg/dL, lipoprotein(a) not raised; no diabetes; status draft. **S**

## Plan

- High blood pressure: home monitoring with a validated upper-arm cuff, twice a day, with readings sent in weekly; single-pill losartan 50 mg with hydrochlorothiazide 12.5 mg from today, chosen as two first-line drugs for stage 2 hypertension and a low-cost generic; basic metabolic panel in two weeks; target below 130/80 mmHg; less salt (no more than 1,500 to 2,300 mg a day), the DASH pattern, and regular walking. Guideline: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025); CMID: Clinical Monitoring Intelligence Database, hypertension, hyperlipidemia and ischemic heart disease monographs (2026) **S**
- Cardiology consultation for exertional breathlessness and chest tightness with left ventricular hypertrophy on the ECG: the cause, the type of hypertrophy, sudden cardiac death risk, coronary risk testing, and whether he can keep refereeing. Guideline: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025); 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (2023); 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain (2021) **S**
- Evaluation at intake: resting ECG, basic metabolic panel, TSH, HbA1c, lipid panel, one-time lipoprotein(a) and urine albumin-to-creatinine ratio; stop and rest, and call the same day for chest discomfort at rest or lasting more than a few minutes, fainting or palpitations; referee only short undercards until the consultation. Guideline: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025); 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain (2021); 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia (2026) **S**
- Money worries and mood: PHQ-9 and GAD-7 at intake and at six months; generic once-daily medicines at the lowest cost; a social needs screen; brief support and problem-solving at each visit. Guideline: Depression and Suicide Risk in Adults: Screening (2023); Anxiety Disorders in Adults: Screening (2023) **S**

## Guideline basis

- 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025), American Heart Association and American College of Cardiology (Circulation 2025;152(11):e114-e218)
- 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (2023), American Heart Association and American College of Cardiology (Circulation 2023;148(9):e9-e119)
- 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain (2021), American Heart Association and American College of Cardiology (Circulation 2021;144(22):e368-e454)
- 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia (2026), American College of Cardiology and American Heart Association (Circulation 2026;153(17):e1154-e1276)
- CMID: Clinical Monitoring Intelligence Database, hypertension, hyperlipidemia and ischemic heart disease monographs (2026), Aether Forge
- Depression and Suicide Risk in Adults: Screening (2023), U.S. Preventive Services Task Force
- Anxiety Disorders in Adults: Screening (2023), U.S. Preventive Services Task Force
